Vanda Pharmaceuticals Announces Participation at Evercore ISI's Catalyst Day
Vanda Pharmaceuticals (Nasdaq: VNDA) has announced its participation in Evercore ISI's Catalyst Day on October 18, 2021.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Vanda Pharmaceuticals (Nasdaq: VNDA) has announced its participation in Evercore ISI's Catalyst Day on October 18, 2021. CEO Mihael H. Polymeropoulos will engage in a virtual fireside chat at 1:30 PM ET. Vanda Pharmaceuticals focuses on developing innovative therapies for unmet medical needs. For further details, visit www.vandapharma.com.
Positive
- Participation in Evercore ISI's Catalyst Day may enhance visibility and investor relations.
Negative
- None.
Details
News Market Reaction – VNDA
The recorded move for VNDA in the trading session of this news was +0.38%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
WASHINGTON, Oct. 14, 2021 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that it will participate at Evercore ISI's Catalyst Day on Monday, October 18, 2021. Mihael H. Polymeropoulos, M.D., Vanda's President, CEO and Chairman of the Board, will take part in a virtual fireside chat at 1:30 PM ET.
About Vanda Pharmaceuticals Inc.
Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on Twitter @vandapharma.
Corporate Contact:
AJ Jones II
Chief Corporate Affairs and Communications Officer
Vanda Pharmaceuticals Inc.
(202) 734-3400
pr@vandapharma.com
Elizabeth Van Every
Head of Corporate Affairs
Vanda Pharmaceuticals Inc.
(202) 734-3400
pr@vandapharma.com
Kevin Moran
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
(202) 734-3400
pr@vandapharma.com
View original content:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-at-evercore-isis-catalyst-day-301400804.html
SOURCE Vanda Pharmaceuticals Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.